Optimizing heart failure treatment using registry data
Part of Heart & circulation clinical trials.
This trial uses a national heart failure registry to see if a new way of monitoring treatment can help optimize therapy for people with heart failure and reduced ejection fraction (a weak heart pump). It may lead to better medication adjustments over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart failure has lasted more than 6 months
- Your heart's pumping ability (ejection fraction) is 40% or less
- Your current heart failure treatment is not being adjusted right now
- You are able to understand and follow the study process
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This study aims to improve heart failure treatment for people who have limited access to care in Denver. If you have heart failure with reduced pumping ability and are a patient in the Denver Health system, this trial may help find better ways to manage your condition.
This study tests a new way to find people who might develop heart failure early, using electronic health records. If you are at risk, screening could help start care sooner and prevent serious problems.
This study tests different treatments for heart failure, a condition where the heart doesn't pump blood as well as it should. It aims to find better ways to manage symptoms and improve quality of life for people who are hospitalized or living with heart failure at home.
This trial tests whether adjusting heart failure medications in women can improve their recovery and outcomes. It focuses on women who have been recently hospitalized for acute heart failure and are not yet on optimal medication doses.
This trial tests whether safely increasing the dose of standard heart failure medications can improve outcomes in people with a weak heart pump, while keeping a close eye on kidney function. It may be a good fit if you have heart failure with reduced ejection fraction and are not yet on the highest recommended doses of your medicines.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.